BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Clark IA, Vissel B. Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease. Br J Pharmacol 2015;172:3714-27. [PMID: 25939581 DOI: 10.1111/bph.13181] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Ha JS, Choi HR, Kim IS, Kim EA, Cho SW, Yang SJ. Hypoxia-Induced S100A8 Expression Activates Microglial Inflammation and Promotes Neuronal Apoptosis. Int J Mol Sci 2021;22:1205. [PMID: 33530496 DOI: 10.3390/ijms22031205] [Reference Citation Analysis]
2 Jin M, Shiwaku H, Tanaka H, Obita T, Ohuchi S, Yoshioka Y, Jin X, Kondo K, Fujita K, Homma H, Nakajima K, Mizuguchi M, Okazawa H. Tau activates microglia via the PQBP1-cGAS-STING pathway to promote brain inflammation. Nat Commun 2021;12:6565. [PMID: 34782623 DOI: 10.1038/s41467-021-26851-2] [Reference Citation Analysis]
3 Bedoui Y, Neal JW, Gasque P. The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation. J Neuroimmune Pharmacol 2018;13:309-29. [PMID: 29909495 DOI: 10.1007/s11481-018-9793-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
4 Biragyn A, Aliseychik M, Rogaev E. Potential importance of B cells in aging and aging-associated neurodegenerative diseases. Semin Immunopathol 2017;39:283-94. [PMID: 28083646 DOI: 10.1007/s00281-016-0615-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
5 Clark IA, Vissel B. Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases. Br J Pharmacol 2018;175:3859-75. [PMID: 30097997 DOI: 10.1111/bph.14471] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
6 Cattaneo A, Cattane N, Galluzzi S, Provasi S, Lopizzo N, Festari C, Ferrari C, Guerra UP, Paghera B, Muscio C, Bianchetti A, Volta GD, Turla M, Cotelli MS, Gennuso M, Prelle A, Zanetti O, Lussignoli G, Mirabile D, Bellandi D, Gentile S, Belotti G, Villani D, Harach T, Bolmont T, Padovani A, Boccardi M, Frisoni GB; INDIA-FBP Group. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly. Neurobiol Aging. 2017;49:60-68. [PMID: 27776263 DOI: 10.1016/j.neurobiolaging.2016.08.019] [Cited by in Crossref: 364] [Cited by in F6Publishing: 333] [Article Influence: 60.7] [Reference Citation Analysis]
7 Clark IA, Vissel B. The meteorology of cytokine storms, and the clinical usefulness of this knowledge. Semin Immunopathol 2017;39:505-16. [PMID: 28451786 DOI: 10.1007/s00281-017-0628-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
8 Lindhout IA, Murray TE, Richards CM, Klegeris A. Potential neurotoxic activity of diverse molecules released by microglia. Neurochem Int 2021;148:105117. [PMID: 34186114 DOI: 10.1016/j.neuint.2021.105117] [Reference Citation Analysis]
9 Ishida N, Ishihara Y, Ishida K, Tada H, Funaki-Kato Y, Hagiwara M, Ferdous T, Abdullah M, Mitani A, Michikawa M, Matsushita K. Periodontitis induced by bacterial infection exacerbates features of Alzheimer's disease in transgenic mice. NPJ Aging Mech Dis 2017;3:15. [PMID: 29134111 DOI: 10.1038/s41514-017-0015-x] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 13.4] [Reference Citation Analysis]
10 Burgoyne RA, Fisher AJ, Borthwick LA. The Role of Epithelial Damage in the Pulmonary Immune Response. Cells 2021;10:2763. [PMID: 34685744 DOI: 10.3390/cells10102763] [Reference Citation Analysis]
11 Herbert J, Lucassen PJ. Depression as a risk factor for Alzheimer's disease: Genes, steroids, cytokines and neurogenesis - What do we need to know? Front Neuroendocrinol 2016;41:153-71. [PMID: 26746105 DOI: 10.1016/j.yfrne.2015.12.001] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 8.9] [Reference Citation Analysis]
12 Syeda T, Sanchez-Tapia M, Pinedo-Vargas L, Granados O, Cuervo-Zanatta D, Rojas-Santiago E, Díaz-Cintra SA, Torres N, Perez-Cruz C. Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease. J Alzheimers Dis 2018;66:1657-82. [PMID: 30475761 DOI: 10.3233/JAD-180556] [Cited by in Crossref: 22] [Cited by in F6Publishing: 10] [Article Influence: 7.3] [Reference Citation Analysis]
13 Lukiw WJ. Bacteroides fragilis Lipopolysaccharide and Inflammatory Signaling in Alzheimer's Disease. Front Microbiol 2016;7:1544. [PMID: 27725817 DOI: 10.3389/fmicb.2016.01544] [Cited by in Crossref: 97] [Cited by in F6Publishing: 89] [Article Influence: 16.2] [Reference Citation Analysis]
14 Yan L, Xie Y, Satyanarayanan SK, Zeng H, Liu Q, Huang M, Ma Y, Wan JB, Yao X, Su KP, Su H. Omega-3 polyunsaturated fatty acids promote brain-to-blood clearance of β-Amyloid in a mouse model with Alzheimer's disease. Brain Behav Immun 2020;85:35-45. [PMID: 31132459 DOI: 10.1016/j.bbi.2019.05.033] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
15 Clark IA, Vissel B. Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches. J Alzheimers Dis 2021;79:931-48. [PMID: 33459706 DOI: 10.3233/JAD-201186] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
16 Zhao Y, Lukiw WJ. Microbiome-Mediated Upregulation of MicroRNA-146a in Sporadic Alzheimer's Disease. Front Neurol 2018;9:145. [PMID: 29615954 DOI: 10.3389/fneur.2018.00145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
17 Clark IA. How diseases caused by parasites allowed a wider understanding of disease in general: my encounters with parasitology in Australia and elsewhere over the last 50 years. Int J Parasitol 2021:S0020-7519(21)00298-8. [PMID: 34757090 DOI: 10.1016/j.ijpara.2021.10.002] [Reference Citation Analysis]
18 Zheng JY, Sun J, Ji CM, Shen L, Chen ZJ, Xie P, Sun YZ, Yu RT. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling. Neurobiol Aging 2017;54:112-32. [PMID: 28366226 DOI: 10.1016/j.neurobiolaging.2017.03.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
19 Clark IA, Vissel B. Neurodegenerative disease treatments by direct TNF reduction, SB623 cells, maraviroc and irisin and MCC950, from an inflammatory perspective – a Commentary. Expert Review of Neurotherapeutics 2019;19:535-43. [DOI: 10.1080/14737175.2019.1618710] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
20 Clark IA, Vissel B. The Inflammatory Nature of Post-surgical Delirium Predicts Benefit of Agents With Anti-TNF Effects, Such as Dexmedetomidine. Front Neurosci 2018;12:257. [PMID: 29725287 DOI: 10.3389/fnins.2018.00257] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
21 Angelucci F, Cechova K, Amlerova J, Hort J. Antibiotics, gut microbiota, and Alzheimer's disease. J Neuroinflammation 2019;16:108. [PMID: 31118068 DOI: 10.1186/s12974-019-1494-4] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 19.3] [Reference Citation Analysis]
22 Rahimi F. Aptamers Selected for Recognizing Amyloid β-Protein-A Case for Cautious Optimism. Int J Mol Sci 2018;19:E668. [PMID: 29495486 DOI: 10.3390/ijms19030668] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
23 Momtazmanesh S, Perry G, Rezaei N. Toll-like receptors in Alzheimer's disease. Journal of Neuroimmunology 2020;348:577362. [DOI: 10.1016/j.jneuroim.2020.577362] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Buccellato FR, D'Anca M, Fenoglio C, Scarpini E, Galimberti D. Role of Oxidative Damage in Alzheimer's Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery. Antioxidants (Basel) 2021;10:1353. [PMID: 34572985 DOI: 10.3390/antiox10091353] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Richards RI, Robertson SA, Kastner DL. Neurodegenerative diseases have genetic hallmarks of autoinflammatory disease. Hum Mol Genet 2018;27:R108-18. [PMID: 29684205 DOI: 10.1093/hmg/ddy139] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
26 Besedovsky L, Lange T, Haack M. The Sleep-Immune Crosstalk in Health and Disease. Physiol Rev 2019;99:1325-80. [PMID: 30920354 DOI: 10.1152/physrev.00010.2018] [Cited by in Crossref: 198] [Cited by in F6Publishing: 176] [Article Influence: 66.0] [Reference Citation Analysis]
27 Wen M, Ding L, Zhang L, Zhang T, Teruyoshi Y, Wang Y, Xue C. Eicosapentaenoic Acid-Enriched Phosphatidylcholine Mitigated Aβ1-42-Induced Neurotoxicity via Autophagy-Inflammasome Pathway. J Agric Food Chem 2019;67:13767-74. [PMID: 31722531 DOI: 10.1021/acs.jafc.9b05947] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
28 Witkowski A, Carta S, Lu R, Yokoyama S, Rubartelli A, Cavigiolio G. Oxidation of methionine residues in human apolipoprotein A-I generates a potent pro-inflammatory molecule. J Biol Chem 2019;294:3634-46. [PMID: 30635405 DOI: 10.1074/jbc.RA118.005663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
29 Morris GP, Clark IA, Vissel B. Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer's disease. Acta Neuropathol 2018;136:663-89. [PMID: 30349969 DOI: 10.1007/s00401-018-1918-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 77] [Article Influence: 21.8] [Reference Citation Analysis]
30 Zhao Y, Cong L, Lukiw WJ. Lipopolysaccharide (LPS) Accumulates in Neocortical Neurons of Alzheimer's Disease (AD) Brain and Impairs Transcription in Human Neuronal-Glial Primary Co-cultures. Front Aging Neurosci 2017;9:407. [PMID: 29311897 DOI: 10.3389/fnagi.2017.00407] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
31 Tortarolo M, Lo Coco D, Veglianese P, Vallarola A, Giordana MT, Marcon G, Beghi E, Poloni M, Strong MJ, Iyer AM, Aronica E, Bendotti C. Amyotrophic Lateral Sclerosis, a Multisystem Pathology: Insights into the Role of TNFα. Mediators Inflamm 2017;2017:2985051. [PMID: 29081600 DOI: 10.1155/2017/2985051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
32 Zhao Y, Cong L, Jaber V, Lukiw WJ. Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer's Disease Brain. Front Immunol 2017;8:1064. [PMID: 28928740 DOI: 10.3389/fimmu.2017.01064] [Cited by in Crossref: 52] [Cited by in F6Publishing: 56] [Article Influence: 10.4] [Reference Citation Analysis]
33 Wei Z, Koya J, Reznik SE. Insulin Resistance Exacerbates Alzheimer Disease via Multiple Mechanisms. Front Neurosci 2021;15:687157. [PMID: 34349617 DOI: 10.3389/fnins.2021.687157] [Reference Citation Analysis]
34 Jankovska N, Olejar T, Matej R. Extracellular Amyloid Deposits in Alzheimer's and Creutzfeldt-Jakob Disease: Similar Behavior of Different Proteins? Int J Mol Sci 2020;22:E7. [PMID: 33374972 DOI: 10.3390/ijms22010007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zhao Y, Jaber V, Lukiw WJ. Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus. Front Cell Infect Microbiol. 2017;7:318. [PMID: 28744452 DOI: 10.3389/fcimb.2017.00318] [Cited by in Crossref: 138] [Cited by in F6Publishing: 135] [Article Influence: 27.6] [Reference Citation Analysis]
36 Lian Y, Gong H, Wu T, Su W, Zhang Y, Yang Y, Peng W, Zhang T, Zhou J, Jiang C, Wang Y. Ds-HMGB1 and fr-HMGB induce depressive behavior through neuroinflammation in contrast to nonoxid-HMGB1. Brain, Behavior, and Immunity 2017;59:322-32. [DOI: 10.1016/j.bbi.2016.09.017] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
37 Lin D, Zhu X, Li J, Yao Y, Guo M, Xu H. Ulinastatin alleviates mitochondrial damage and cell apoptosis induced by isoflurane in human neuroglioma H4 cells. Hum Exp Toxicol 2020;39:1417-25. [PMID: 32441136 DOI: 10.1177/0960327120926242] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Kamer AR, Craig RG, Niederman R, Fortea J, de Leon MJ. Periodontal disease as a possible cause for Alzheimer's disease. Periodontol 2000 2020;83:242-71. [PMID: 32385876 DOI: 10.1111/prd.12327] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
39 Michael J, Marschallinger J, Aigner L. The leukotriene signaling pathway: a druggable target in Alzheimer’s disease. Drug Discovery Today 2019;24:505-16. [DOI: 10.1016/j.drudis.2018.09.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 7.3] [Reference Citation Analysis]
40 Mishra A, Brinton RD. Inflammation: Bridging Age, Menopause and APOEε4 Genotype to Alzheimer's Disease. Front Aging Neurosci 2018;10:312. [PMID: 30356809 DOI: 10.3389/fnagi.2018.00312] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
41 Yao Y, Huang JZ, Chen Y, Hu HJ, Tang X, Li X. Effects and mechanism of amyloid β1-42 on mitochondria in astrocytes. Mol Med Rep 2018;17:6997-7004. [PMID: 29568933 DOI: 10.3892/mmr.2018.8761] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
42 Mullane K, Williams M. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics. Biochem Pharmacol 2018;158:376-401. [PMID: 30273552 DOI: 10.1016/j.bcp.2018.09.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
43 Sarhan M, Land WG, Tonnus W, Hugo CP, Linkermann A. Origin and Consequences of Necroinflammation. Physiol Rev 2018;98:727-80. [PMID: 29465288 DOI: 10.1152/physrev.00041.2016] [Cited by in Crossref: 73] [Cited by in F6Publishing: 65] [Article Influence: 18.3] [Reference Citation Analysis]
44 Zhao Y, Lukiw WJ. Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration. Mol Neurobiol 2018;55:9100-7. [PMID: 29637444 DOI: 10.1007/s12035-018-1015-y] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 7.3] [Reference Citation Analysis]
45 Mullane K, Williams M. Alzheimer’s disease beyond amyloid: Can the repetitive failures of amyloid-targeted therapeutics inform future approaches to dementia drug discovery? Biochemical Pharmacology 2020;177:113945. [DOI: 10.1016/j.bcp.2020.113945] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
46 Marciani DJ. Development of an Effective Alzheimer’s Vaccine. Immunology. Elsevier; 2018. pp. 149-69. [DOI: 10.1016/b978-0-12-809819-6.00011-3] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Festoff BW, Sajja RK, van Dreden P, Cucullo L. HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer's disease. J Neuroinflammation 2016;13:194. [PMID: 27553758 DOI: 10.1186/s12974-016-0670-z] [Cited by in Crossref: 99] [Cited by in F6Publishing: 88] [Article Influence: 16.5] [Reference Citation Analysis]
48 Marciani DJ. Rejecting the Alzheimer's disease vaccine development for the wrong reasons. Drug Discov Today 2017;22:609-14. [PMID: 27989721 DOI: 10.1016/j.drudis.2016.10.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
49 Clark IA, Vissel B. Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents. J Neuroinflammation. 2016;13:236. [PMID: 27596607 DOI: 10.1186/s12974-016-0708-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 8.8] [Reference Citation Analysis]
50 Wiatrak B, Balon K. Protective Activity of Aβ on Cell Cultures (PC12 and THP-1 after Differentiation) Preincubated with Lipopolysaccharide (LPS). Mol Neurobiol 2021;58:1453-64. [PMID: 33188619 DOI: 10.1007/s12035-020-02204-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
51 Lee HJ, Savelieff MG, Kang J, Brophy MB, Nakashige TG, Lee SJC, Nolan EM, Lim MH. Calprotectin influences the aggregation of metal-free and metal-bound amyloid-β by direct interaction. Metallomics 2018;10:1116-27. [DOI: 10.1039/c8mt00091c] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
52 Citron BA, Ameenuddin S, Uchida K, Suo WZ, Santacruz K, Festoff BW. Membrane lipid peroxidation in neurodegeneration: Role of thrombin and proteinase-activated receptor-1. Brain Research 2016;1643:10-7. [DOI: 10.1016/j.brainres.2016.04.071] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
53 Lukiw WJ, Cong L, Jaber V, Zhao Y. Microbiome-Derived Lipopolysaccharide (LPS) Selectively Inhibits Neurofilament Light Chain (NF-L) Gene Expression in Human Neuronal-Glial (HNG) Cells in Primary Culture. Front Neurosci 2018;12:896. [PMID: 30568571 DOI: 10.3389/fnins.2018.00896] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
54 Currais A, Fischer W, Maher P, Schubert D. Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain. FASEB J 2017;31:5-10. [PMID: 28049155 DOI: 10.1096/fj.201601184] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 11.2] [Reference Citation Analysis]
55 Dejakaisaya H, Kwan P, Jones NC. Astrocyte and glutamate involvement in the pathogenesis of epilepsy in Alzheimer's disease. Epilepsia 2021;62:1485-93. [PMID: 33971019 DOI: 10.1111/epi.16918] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]